TrialBlood cancer journal2022

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial.

Karthik Ramasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.